RE:New Press Release - SIRONA BIOCHEM Corporate Update April 2024I like the anti-aging transparancy. Don't think it's fair to expect more. Without current management history we should trade well above 40 cents.
Came to realize that there's an additional source of cash - licensing fee paid by the subsidiary to the parent company.
The vast costs over the years to bring anti-aging to it's current state will provide the company with a base valuation that the partner must benchmark their investment against, meaning that the partner must provide Sirona Laboratories with a lot of cash to get in, more then enough to cover a licensing fee along with other costs,